The effectiveness and safety of lobaplatin or cisplatin combined with etoposide for advanced small cell lung cancer: a prospective, dynamic randomized, positive controlled, multi-center clinical trial.

Trial Profile

The effectiveness and safety of lobaplatin or cisplatin combined with etoposide for advanced small cell lung cancer: a prospective, dynamic randomized, positive controlled, multi-center clinical trial.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Cisplatin; Etoposide; Lobaplatin
  • Indications Small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top